The effects of macrolides on the expression of bacterial virulence mechanisms

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 5, 1998, Pages 505-512

  Shryock, Thomas R ^a   Mortensen, Joel E ^b,c   Baumholtz, Michael ^c  

^a ELANCO ANIMAL HEALTH   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; MIOKAMYCIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TYLOSIN;

BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIOSTASIS; BACTERIUM ADHERENCE; DRUG EFFICACY; HUMAN; LEUKOCYTE; MINIMUM INHIBITORY CONCENTRATION; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL ADHESION; BACTERIAL INFECTIONS; BACTERIAL TOXINS; BLOOD BACTERICIDAL ACTIVITY; HUMANS; LEUKOCYTES; MACROLIDES; VIRULENCE;

EID: 0031971757     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.5.505     Document Type: Review

References (53)

1. Bryskier, A., Agouridas, C. & Gase, J.-C. (1993). Classification of macrolide antibiotics. In Macrolides, Chemistry, Pharmacology and Clinical Uses (Bryskier, A. J., Butzler, J.-P., Neu, H. C. & Tulkens, P. M., Eds), pp. 5-66. Arnett Blackwell, Boston, MA.
2. Kirst, H. A. (1992). Macrolides. In Kirk-Othmer Encyclopedia of Chemical Technology, 4th edn, Vol. 3, pp. 169-213. J. Wiley & Sons, New York, NY.
3. Champney, W. S. & Burdine, R. (1995). Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 39, 2141-4.
4. Butts, J. D. (1994). Intracellular concentrations of antibacterial agents and related clinical implications. Clinical Pharmacokinetics 27, 63-84.
5. Lorian, V. (1993). Medical relevance of low concentrations of antibiotics. Journal of Antimicrobial Chemotherapy 31, Suppl. D, 137-48.
6. Tateda, K., Ishii, Y., Matsumoto, T., Furuya, N., Nagashima, M., Matsunaga, T. et al. (1996). Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrobial Agents and Chemotherapy 40, 2271-5.
7. Gemmell, C. G. & Lorian, V. (1996). Effects of low concentrations of antibiotics on bacterial ultrastructure, virulence, and susceptibility to immunodefences: clinical significance. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 397-452. Williams & Wilkins, Philadelphia, PA.
8. Tulkens, P. M. (1991). Intracellular distribution and activity of antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 10, 100-6.
9. Gladue, R. P., Bright, G. M., Isaacson, R. E. & Newborg, M. F. (1989). In vitro and in vivo uptake of azithromycin (CP-62, 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrobial Agents and Chemotherapy 33, 277-82.
10. Gemmell, C. G. (1991). Macrolides and host defences to respiratory tract pathogens. Journal of Hospital Infection 19, Suppl. A, 11-19.
11. Gemmell, C. G. (1993). Antibiotics and neutrophil function -potential immunomodulating activities. Journal of Antimicrobial Chemotherapy 31, Suppl. B, 23-33.
12. McDonald, P. J. & Pruul, H. (1992). Macrolides and the immune system. Scandanavian Journal of Infectious Diseases 83, Suppl., 34-40.
13. Stevens, D. L. (1996). Immune modulatory effects of antibiotics. Current Opinion in Infectious Diseases 9, 165-9.
14. Mims, C. (1987). The Pathogenesis of Infectious Disease, 3rd edn. Academic Press, San Diego, CA.
15. Arp, L. H. (1988). Bacterial infection of mucosal surfaces: an overview of cellular and molecular mechanisms. In Virulence Mechanisms of Bacterial Pathogens (Roth, J., Ed.), pp. 3-27. American Society for Microbiology, Washington, DC.
16. Patti, J. M., Allen, B. L, McGavin, M. J. & Hook, M. (1994). MSCRAMM-mediated adherence of microorganisms to host tissues. Annual Review of Microbiology 48, 585-617.
17. Piatti, G. (1994). Bacterial adhesion to respiratory mucosa and its modulation by antibiotics at sub-inhibitory concentrations. Pharmacological Research 30, 289-99.
18. Shibl, A. M. (1985). Effects of antibiotics on adherence of microorganisms to epithelial cell surfaces. Review of Infectious Diseases 7, 51-65.
19. Scaglione, F., Demartini, G., Dugnani, S., Ferrara, F., Maccarinelli, G., Cocuzza, C. et al. (1994). Effect of antibiotics on Bordetella pertussis adhering activity: hypothesis regarding mechanism of action. Chemotherapy 40, 215-20.
20. Ishida, L. K., Ikeda, K., Tanno, N., Takasaka, T., Nishioka, K. & Tanno, Y. (1995). Erythromycin inhibits adhesion of Pseudomonas aeruginosa and Branhamella catarrhalis to human nasal epithelial cells. American Journal of Rhinology 9, 53-5.
21. Gorby, G. L. & McGee, Z. A. (1990). Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. Antimicrobial Agents and Chemotherapy 34, 2445-8.
22. Yamasaki, T., Ichimiya, T., Hirai, K., Hiramatsu, K. & Nasu, M. (1997). Effect of antimicrobial agents on the piliation of Pseudomonas aeruginosa and adherence to mouse tracheal epithelium. Journal of Chemotherapy 9, 32-7.
23. Salit, I. E. (1983). Effect of subinhibitory concentrations of antimicrobials on meningococcal adherence. Canadian Journal of Microbiology 29, 369-76.
24. Chopra, I. & Hacker, K. (1986). Inhibition of k88-mediated adhesion of Escherichia coli to mammalian receptors by antibiotics that affect bacterial protein synthesis. Journal of Antimicrobial Chemotherapy 18, 441-51.
25. Proctor, R. A., Hamill, R. J., Mosher, D. F., Textor, J. A. & Olbrantz, P. J. (1983). Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. Journal of Antimicrobial Chemotherapy 12, Suppl.C, 85-95.
26. Mascellino, M. T., Catania, S., DeVito, M. L. & De Bac, C. (1988). Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of Gram-positive bacteria. Microbiologica 11, 231-41.
27. Braga, P. C., Piatti, G. & Allegra, L. (1991). Subinhibitory concentrations of rokitamycin alter the adherence of Staphylococcus aureus to human cells. International Journal of Experimental and Clinical Chemotherapy 4, 237-41.
28. Braga, P. C. & Piatti, G. (1993). Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. Chemotherapy 39, 432-7.
29. Braga, P. C. & Piatti, G. (1993). Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. Journal of Chemotherapy 5, 159-63.
30. Braga, P. C. (1994). Effects of subinhibitory concentrations of seven macrolides and four fluoroquinolones on adhesion of Staphylococcus aureus to human mucosal cells. Chemotherapy 40, 304-10.
31. Doig, P., Smith, N. R., Todd, T. & Irvin, R. T. (1987). Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infection and Immunity 55, 1517-22.
32. Pedersen, S. S., Hoiby, N., Espersen, F. & Koch, C. (1992). Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47, 6-13.
33. Majtan, V. & Hybenova, D. (1996). Inhibition of Pseudomonas aeruginosa alginate expression by subinhibitory concentrations of antibiotics. Folia Microbiologica 44, 61-4.
34. Pollack, M. (1984). The virulence of Pseudomonas aeruginosa. Reviews of Infectious Diseases 6, Suppl. 3, S617-26.
35. Grimwood, K., To, M., Rabin, H. R. & Woods, D. E. (1989). Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrobial Agents and Chemotherapy 33, 41-7.
36. Kita, E., Sawaki, M., Oku, D., Hamuro, A., Mikasa, K., Konishi, M. et al. (1991). Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. Journal of Antimicrobial Chemotherapy 27, 273-84.
37. Hirakata, Y., Kaku, M., Mizukane, R., Ishida, K., Furuya, N., Matsumoto, T. et al. (1992). Potential effects of erythromycin on host defence systems and virulence of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 36, 1922-7.
38. Molinari, G., Paglia, P. & Schito, G. C. (1992). Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. European Journal of Clinical Microbiology and Infectious Diseases 11, 469-71.
39. Mizukane, R., Hirakata, Y., Kaku, M., Ishii, Y., Furuya, N., Ishida, K. et al. (1994). Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 38, 528-33.
40. Moneib, N. A., Shibl, A. M., el-Said, M. A. & el-Masry, E. M. (1993). Macrolides induced suppression of virulence factors produced by Staphylococcus aureus. Journal of Chemotherapy 5, 289-92.
41. Davis, B. D. (1990). Bacterial Architecture. In Microbiology, 4th edn (Davis, B. D., Dulbecco, R., Eisen, H. N. & Ginsberg, H. S., Eds), p. 24. J. B. Lippincott, Philadelphia, PA.
42. Montie, T. C., Doyle-Huntzinger, D., Craven, R. C. & Holder, I. A. (1982). Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infection and Immunity 38, 1296-8.
43. Molinari, G., Guzman, C. A., Pesce, A. & Schito, G. C. (1993). Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. Journal of Antimicrobial Chemotherapy 31, 681-8.
44. Woolcock, J. B. (1988). Bacterial resistance to humoral defense mechanisms: an overview. In Virulence Mechanisms of Bacterial Pathogens (Roth, J., Ed.), pp. 73-93. American Society for Microbiology, Washington, DC.
45. Taylor, P. W. (1988). Bacterial resistance to complement. In Virulence Mechanisms of Bacterial Pathogens (Roth, J., Ed.), pp. 107-20. American Society for Microbiology, Washington, DC.
46. Tateda, K., Ishii, Y., Hirakata, Y., Matsumoto, T., Ohno, A. & Yamaguchi, K. (1994). Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. Journal of Antimicrobial Chemotherapy 34, 931-42.
47. Tateda, K., Furuya, M., Hikarata, Y., Ohno, A., Kaneko, Y., Miyazaki, S. et al. (1991). Effect of macrolide antibiotics on human serum-bactericidal sensitivity of Pseudomonas aeruginosa S-6. Kansensogaku Zasshi (Journal of the Japanese Association for Infectious Diseases) 65, 1337-43.
48. Tateda, K., Hirakata, Y., Furuya, N., Ohno, A. & Yamaguchi, K. (1993). Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 675-80.
49. Watanabe, T., Kanno, M., Tejima, E. & Orikasa, Y. (1992). Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase. Drugs under Experimental and Clinical Research 18, 81-8.
50. Saverino, D., Debbia, E. A., Marchese, A., Pesce, A., Botta, G. A. & Schito, G. C. (1993). Plasmid loss from Gram-negative bacteria exposed to subinhibitory concentrations of β-lactam drugs and azithromycin. New Microbiologica 16, 343-50.
51. Reinert, P. (1995). Effets de l'azitnromycine sur la virulence du pyocyanique. Pathologie Biologie 43, 551-3.
52. Kirst, H. A. (1997). Macrolide antibiotics in food-animal health. Expert Opinion on Investigational Drugs 6, 103-17.
53. Stevens, D. L. (1996). Invasive group A streptococcal disease. Infectious Agents and Disease 5, 157-66.